VEGF receptor signalling ? in control of vascular function
The DOI matches its Crossref record; 140 of the 141 references it cites were found in a registry or an index, and 1 are not checked yet.
Abstract
Vascular endothelial growth-factor receptors (VEGFRs) regulate the cardiovascular system. VEGFR1 is required for the recruitment of haematopoietic precursors and migration of monocytes and macrophages, whereas VEGFR2 and VEGFR3 are essential for the functions of vascular endothelial and lymphendothelial cells, respectively. Recent insights have shed light onto VEGFR signal transduction and the interplay between different VEGFRs and VEGF co-receptors in development, adult physiology and disease.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“These proteins collectively contribute to promoting angiogenic activities by influencing endothelial cell proliferation [49,53,54].”
From Mesenchymal Stem/Stromal Cells: Immunomodulatory and Bone Regeneration Potential after Tumor Excision in Osteosarcoma Patients (2023) · cites this paper as [54]
In the citing paper
“Moreover, EVs’ content also encompasses an array of growth factors such as soluble growth factors like VEGF, TGFB1, IL-8, and HGF.”
From Mesenchymal Stem/Stromal Cells: Immunomodulatory and Bone Regeneration Potential after Tumor Excision in Osteosarcoma Patients (2023) · cites this paper as [54]
In the citing paper
“Additionally, miRNAs cargos in MSCs EVs such as miR210, miR126, miR132, and miR21 have been identified as contributors to angiogenesis [49,54].”
From Mesenchymal Stem/Stromal Cells: Immunomodulatory and Bone Regeneration Potential after Tumor Excision in Osteosarcoma Patients (2023) · cites this paper as [54]
In the citing paper
“Flt-1 is one of the main receptors of the vascular endothelial growth factor (VEGF) family widely expressed in the vascular system.33”
From CSF biomarkers of neuroinflammation and cerebrovascular dysfunction in early Alzheimer disease (2018) · cites this paper as [33]
Citations
Cites
Normalization of Tumor Vasculature: An Emerging Concept in Antiangiogenic Therapy
Jain, R. K. (2005) · Science · doi:10.1126/science.1104819 · Cited by 5,527
Abnormal blood vessel development and lethality in embryos lacking a single VEGF allele
Carmeliet, P., Ferreira, V., Breier, G., Pollefeyt, S., Kieckens, L., Gertsenstein, M., Fahrig, M., Vandenhoeck, A., Harpal, K., Eberhardt, C., et al. (1996) · Nature · doi:10.1038/380435a0 · Cited by 4,117 · cited 1×
“Inactivation of a single Vegfa allele in mice results in early lethality at embryonic day (E)11?12 owing to deficient endothelial-cell development and lack of vessel”
BackgroundTumor Cells Secrete a Vascular Permeability Factor That Promotes Accumulation of Ascites Fluid
Senger, D. R., Galli, S. J., Dvorak, A. M., Perruzzi, C. A., Harvey, V. S., & Dvorak, H. F. (1983) · Science · doi:10.1126/science.6823562 · Cited by 3,972
Failure of blood-island formation and vasculogenesis in Flk-1-deficient mice
Shalaby, F., Rossant, J., Yamaguchi, T. P., Gertsenstein, M., Wu, X.-F., Breitman, M. L., & Schuh, A. C. (1995) · Nature · doi:10.1038/376062a0 · Cited by 3,931
Circulating angiogenic factors and the risk of preeclampsia
Levine, R. J., Maynard, S. E., Qian, C., Lim, K.-H., England, L. J., Yu, K. F., Schisterman, E. F., Thadhani, R., Sachs, B. P., Epstein, F. H., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa031884 · Cited by 3,720
Heterozygous embryonic lethality induced by targeted inactivation of the VEGF gene
Ferrara, N., Carver-Moore, K., Chen, H., Dowd, M., Lu, L., O'Shea, K. S., Powell-Braxton, L., Hillan, K. J., & Moore, M. W. (1996) · Nature · doi:10.1038/380439a0 · Cited by 3,628 · cited 1×
“Inactivation of a single Vegfa allele in mice results in early lethality at embryonic day (E)11?12 owing to deficient endothelial-cell development and lack of vessel”
BackgroundVEGFR1-positive haematopoietic bone marrow progenitors initiate the pre-metastatic niche
Kaplan, R. N., Riba, R. D., Zacharoulis, S., Bramley, A. H., Vincent, L., Costa, C., MacDonald, D. D., Jin, D. K., Shido, K., Kerns, S. A., et al. (2005) · Nature · doi:10.1038/nature04186 · Cited by 3,288
Circulating angiogenic factors and the risk of preeclampsia*
(2004) · Obstetrics & Gynecology · doi:10.1097/00006250-200405000-00028 · Cited by 2,615
Regulation of endothelium-derived nitric oxide production by the protein kinase Akt
Fulton, D., Gratton, J.-P., McCabe, T. J., Fontana, J., Fujio, Y., Walsh, K., Franke, T. F., Papapetropoulos, A., & Sessa, W. C. (1999) · Nature · doi:10.1038/21218 · Cited by 2,608
Role of the Flt-1 receptor tyrosine kinase in regulating the assembly of vascular endothelium
Fong, G.-H., Rossant, J., Gertsenstein, M., & Breitman, M. L. (1995) · Nature · doi:10.1038/376066a0 · Cited by 2,606
Cited by
Items 801–900 of 1,013
Constitutive Endocytosis of VEGFR2 Protects the Receptor against Shedding
Basagiannis, D., & Christoforidis, S. (2016) · Journal of Biological Chemistry · doi:10.1074/jbc.m116.730309 · Cited by 58
“VEGFR2 is a receptor-tyrosine kinase that plays a critical role in blood vessel formation and pathological angiogenesis (10, 11).”
BackgroundDanilucci, T. M., dos Santos, P. K., Pachane, B. C., Pisani, G. F. D., Lino, R. L. B., Casali, B. C., Altei, W. F., & Selistre-de-Araújo, H. S. (2019) · Cell Communication and Signaling · doi:10.1186/s12964-019-0339-1 · Cited by 58
Endothelial CDS2 deficiency causes VEGFA-mediated vascular regression and tumor inhibition
Zhao, W., Cao, L., Ying, H., Zhang, W., Li, D., Zhu, X., Xue, W., Wu, S., Cao, M., Fu, C., et al. (2019) · Cell Research · doi:10.1038/s41422-019-0229-5 · Cited by 63
Wu, S., Nishiyama, N., Kano, M. R., Morishita, Y., Miyazono, K., Itaka, K., Chung, U., & Kataoka, K. (2008) · Molecular Therapy · doi:10.1038/mt.2008.90 · Cited by 58
Feed-forward Signaling by Membrane-bound Ligand Receptor Circuit
Caolo, V., van den Akker, N. V. D., Verbruggen, S., Donners, M., Swennen, G., Schulten, H., Waltenberger, J., Post, M., & Molin, D. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.176065 · Cited by 63
LW-215, a newly synthesized flavonoid, exhibits potent anti-angiogenic activity in vitro and in vivo
Zhao, K., Yuan, Y., Lin, B., Miao, Z., Li, Z., Guo, Q., & Lu, N. (2017) · Gene · doi:10.1016/j.gene.2017.11.065 · Cited by 58
HOTAIR in cancer: diagnostic, prognostic, and therapeutic perspectives
Nazari, M., Babakhanzadeh, E., Mollazadeh, A., Ahmadzade, M., Mohammadisoleimani, E., & Hajimaqsoudi, E. (2024) · Cancer Cell International · doi:10.1186/s12935-024-03612-x · Cited by 61
The antitumor potential of Interleukin-27 in prostate cancer
Carlo, E. D., Sorrentino, C., Zorzoli, A., Meo, S. D., Tupone, M. G., Ognio, E., Mincione, G., & Airoldi, I. (2013) · Oncotarget · doi:10.18632/oncotarget.1425 · Cited by 55
“IL-27 caused, in both cell lines, a significant down-regulation of a series of antiangiogenesis related genes namely FGFR3 [21], PTGS1 [22] and, particularly, FLT1 [23], which has been reported to be firmly and strongly expressed in hPCa [24,25] and involved in cancer cell proliferation via autocrine VEGF signaling [2…”
BackgroundInfluentialBruns, A. F., Bao, L., Walker, J. H., & Ponnambalam, S. (2009) · Biochemical Society Transactions · doi:10.1042/bst0371193 · Cited by 54
Common Responses of Tumors and Wounds to Hypoxia
Payen, V. L., Brisson, L., Dewhirst, M. W., & Sonveaux, P. (2015) · The Cancer Journal · doi:10.1097/ppo.0000000000000098 · Cited by 56
“Copyright © 2015 Wolters Kluwer H proteins) and of their receptors (VEGFR1–3, existing as soluble or membrane-bound homodimers or heterodimers associated with coreceptors) are numerous and still partially uncharacterized.(129) VEGF-A (a homodimeric glycoprotein) and VEGFR2 (a receptor tyrosine kinase) are both induced…”
BackgroundAdvances in Growth Factor Delivery for Therapeutic Angiogenesis
Said, S. S., Pickering, J. G., & Mequanint, K. (2012) · Journal of Vascular Research · doi:10.1159/000345108 · Cited by 55
Anderson, S. M., Shergill, B. S., Barry, Z. T., Manousiouthakis, E., Chen, T. T., Botvinick, E. L., Platt, M. O., Iruela‐Arispe, M. L., & Segura, T. (2011) · Integrative Biology · doi:10.1039/c1ib00037c · Cited by 55
Vériter, S., Aouassar, N., Adnet, P.-Y., Paridaens, M., Stuckman, C., Jordan, B. F., Karroum, O., Gallez, B., Gianello, P., & Dufrane, D. (2011) · Biomaterials · doi:10.1016/j.biomaterials.2011.02.061 · Cited by 55
Hewett, P. W., Fujisawa, T., Sissaoui, S., Cai, M., Gueron, G., Al‐Ani, B., Cudmore, M., Ahmed, F. S., Wong, M. K. K., Wegiel, B., et al. (2014) · Thrombosis and Haemostasis · doi:10.1160/th14-01-0002 · Cited by 55
“VEGF receptor activation leads to phosphorylation of specific tyrosine residues and the association of different adaptor molecules to initiate signal transduction cascades (34).”
BackgroundFreund, K. B., Balaratnasingam, C., Dhrami‐Gavazi, E., McCann, J., & Ghadiali, Q. (2015) · Clinical ophthalmology · doi:10.2147/opth.s80040 · Cited by 61
“60 For example, neuropilin-2 receptor presents VEGF 165 to VEGFR-2 in a manner that enhances the effectiveness of VEGFR-2 signal transduction.”
Osteopontin facilitates tumor metastasis by regulating epithelial–mesenchymal plasticity
Jia, R., Liang, Y., Chen, R., Liu, G., Wang, H., Tang, M., Zhou, X., Wang, H., Yang, Y., Wei, H., et al. (2016) · Cell Death and Disease · doi:10.1038/cddis.2016.422 · Cited by 57
“The binding of VEGF to its receptors induces receptor dimerization and autophosphorylation, leading to the activation of several downstream molecules, including phospholipase Cγ (PLCγ), protein kinase C (PKC), and phosphatidylinositol 3-kinase (PI3K).(30,31) Several studies have reported the VEGFR2 (KDR)/PLCγ/PKC path…”
BackgroundSplice Variants of the RTK Family: Their Role in Tumour Progression and Response to Targeted Therapy
Fayçal, C. A., Hatat, A., Gazzéri, S., & Eymin, B. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18020383 · Cited by 56
“In addition, sVEGFR1 has an anti-oedema role through its ability to interfere with the vascular permeability function of VEGF-A [101,102].”
BackgroundPerspectives on lymphangiogenesis and angiogenesis in cancer
Holopainen, T., Bry, M., Alitalo, K. K., & Saaristo, A. M. (2011) · Journal of Surgical Oncology · doi:10.1002/jso.21808 · Cited by 58
The role of p53 in the alternation of vascular functions
Chan, G. H. H., Chan, E., Kwok, C. T., Leung, G., Lee, S. M., & Seto, S. W. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.981152 · Cited by 60
“Vascular endothelial growth factor (VEGF) promotes angiogenesis through promoting endothelial cell survival, proliferation and migration (Olsson et al., 2006).”
BackgroundTel1/ETV6 Specifies Blood Stem Cells through the Agency of VEGF Signaling
Ciau‐Uitz, A., Pinheiro, P., Gupta, R., Enver, T., & Patient, R. K. (2010) · Developmental Cell · doi:10.1016/j.devcel.2010.02.009 · Cited by 54
“As further confirmation, we obtained a very similar phenotype by depletion of Flk1, the receptor likely to be relaying VEGF signaling at this time (Olsson et al., 2006) (Figures 5D–5F).”
BackgroundResultWeddell, J. C., & Imoukhuede, P. I. (2014) · PLoS ONE · doi:10.1371/journal.pone.0097271 · Cited by 54
“This VEGFR1 migratory function is also observed in macrophages [45,46], monocytes [47–49], and endothelial cells [50].”
VEGFR1 receptor tyrosine kinase localization to the Golgi apparatus is calcium-dependent
Mittar, S., Ulyatt, C., Howell, G. J., Bruns, A. F., Zachary, I. C., Walker, J. H., & Ponnambalam, S. (2009) · Experimental Cell Research · doi:10.1016/j.yexcr.2008.12.020 · Cited by 54
“VEGF-A stimulation of VEGFR1 and VEGFR2 is known to result in recruitment of phospholipase Cγ1 (PLCγ1) resulting in downstream signaling due to elevation of cytosolic calcium levels [3, 5, 20].”
BackgroundMonchaux, E., & Vermette, P. (2007) · Biomacromolecules · doi:10.1021/bm7007907 · Cited by 54
Fraineau, S., Monvoisin, A., Clarhaut, J. A., Talbot, J., Simonneau, C., Kanthou, C., Kanse, S. M., Philippe, M., & Benzakour, O. (2012) · Blood · doi:10.1182/blood-2012-05-429183 · Cited by 57
Karnezis, T., Shayan, R., Fox, S. B., Achen, M. G., & Stacker, S. A. (2012) · Oncotarget · doi:10.18632/oncotarget.593 · Cited by 57
“In response to binding these growth factors, VEGFR-3 forms homodimers or heterodimers with VEGFR-2 which leads to activation of the receptor-tyrosine kinase activity inducing autophosphorylation of the receptors; phosphorylated receptors then recruit interacting proteins and, in the case of lymphatics, induce specific…”
BackgroundVEGF-mediated signal transduction in lymphatic endothelial cells
Bahram, F., & Claesson, L. (2009) · Pathophysiology · doi:10.1016/j.pathophys.2009.10.004 · Cited by 57
Cooperative Effects of FGF-2 and VEGF-A in Periodontal Ligament Cells
Yanagita, M., Kojima, Y., Kubota, M., Mori, K., Yamashita, M., Yamada, S., Kitamura, M., & Murakami, S. (2013) · Journal of Dental Research · doi:10.1177/0022034513511640 · Cited by 66
“Signal pathways for cell migration via the FGFreceptor and VEGF-receptor are common and include the PI3K/Rac and p38/ MAPK pathways (Cross and ClaessonWelsh, 2001; Olsson et al., 2006).”
BackgroundRoles of Vascular Endothelial Growth Factor in Amyotrophic Lateral Sclerosis
Pronto‐Laborinho, A. C., Pinto, S., & de Carvalho, M. A. (2014) · BioMed Research International · doi:10.1155/2014/947513 · Cited by 61
“The VEGF-A gene has eight exons and seven introns [52, 53] and several homodimeric VEGF-A isoforms with biological activity have been identified: VEGF121, VEGF121b, VEGF145, VEGF145b, VEFG148, VEGF165 (predominant isoform), VEGF165b, VEGF183, VEGF183b, VEGF189, VEGF189b, and VEGF206 [54–57], respectively, composed of…”
BackgroundTokuyama, W., Mikami, T., Masuzawa, M., & Okayasu, I. (2009) · Human Pathology · doi:10.1016/j.humpath.2009.08.021 · Cited by 54
“Signaling through VEGFR-2 is known to be mediated by multiple signal transduction proteins, including members of the critical MAP kinase pathway [3].”
BackgroundGogiraju, R., Schroeter, M. R., Bochenek, M. L., Hubert, A., Münzel, T. F., Hasenfuss, G. P., & Schäfer, K. (2016) · Cardiovascular Research · doi:10.1093/cvr/cvw101 · Cited by 54
“Previous studies have shown that cardiac angiogenesis in response to stress is regulated by VEGF, 5 which in endothelial cells signals primarily via VEGFR2.(18) At 20 weeks after TAC, significantly higher levels of Figure 2 Effect of endothelial PTP1B deletion on single cardiomyocyte hypertrophy, cardiac angiogenesis,…”
BackgroundSuwarto, S., Nainggolan, L., Sinto, R., Effendi, B., Ibrahim, E., Suryamin, M., & Sasmono, R. T. (2016) · BMC Infectious Diseases · doi:10.1186/s12879-016-1671-3 · Cited by 54
“Damage to platelets, which possibly contribute to thrombocytopenia in dengue patients, results in the release of vascular endothelial growth factor (VEGF) which in turn is responsible for the occurrence of pleural effusions and/or ascites [30, 31].”
BackgroundImportant signals regulating coronary artery angiogenesis
Shoeibi, S., Mozdziak, P. E., & Mohammadi, S. (2017) · Microvascular Research · doi:10.1016/j.mvr.2017.12.002 · Cited by 56
Lakshmikanthan, S., Sobczak, M., Calzi, S. L., Shaw, L. C., Grant, M. B., & Chrzanowska‐Wodnicka, M. (2017) · Journal of Cell Science · doi:10.1242/jcs.207605 · Cited by 54
“VEGF is the critical factor responsible for new blood vessel formation but is also a potent permeabilizing factor, which, under normal conditions, enables the EC junction dissolution that is required for the formation of new vessels (Olsson et al., 2006).”
BackgroundYang, X., Man, X., Cai, S., Yao, Y., Bu, Z., & Zheng, M. (2006) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2006.07.213 · Cited by 54
Refolo, M. G., Lotesoriere, C., Lolli, I. R., Messa, C., & D’Alessandro, R. (2020) · Scientific Reports · doi:10.1038/s41598-020-64195-x · Cited by 53
Alanazi, M. M., Elwan, A., Alsaif, N. A., Obaidullah, A. J., Alkahtani, H. M., Al-Mehizia, A. A., Alsubaie, S. M., Taghour, M. S., & Eissa, I. H. (2021) · Journal of Enzyme Inhibition and Medicinal Chemistry · doi:10.1080/14756366.2021.1945591 · Cited by 53
Endothelial cells as key players in cerebral small vessel disease
Kremer, R., Williams, A., & Wardlaw, J. M. (2025) · Nature reviews. Neuroscience · doi:10.1038/s41583-024-00892-0 · Cited by 59
“Dysfunctional endothelial cells secrete more heat shock protein 90α (HSP90α), inhibiting surrounding oligodendrocyte differentiation 23 , and more vascular endothelial growth factor (VEGF), increasing endothelial cell proliferation and contributing to BBB breakdown 21,59,60 .”
The role of angiogenic and wound-healing factors after spinal cord injury in mammals
Kundi, S., Bicknell, R., & Ahmed, Z. (2013) · Neuroscience Research · doi:10.1016/j.neures.2013.03.013 · Cited by 61
Andrographolide inhibits tumor angiogenesis via blocking VEGFA/VEGFR2-MAPKs signaling cascade
Shen, K., Ji, L., Lü, B., Xu, C. B., Gong, C., Morahan, G., & Wang, Z. (2014) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2014.04.020 · Cited by 53
Willis, C. D., Poluzzi, C., Mongiat, M., & Iozzo, R. V. (2013) · FEBS Journal · doi:10.1111/febs.12164 · Cited by 53
S100B-RAGE dependent VEGF secretion by cardiac myocytes induces myofibroblast proliferation
Tsoporis, J. N., Izhar, S., Proteau, G. A., Slaughter, G., & Parker, T. G. (2011) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2011.08.015 · Cited by 53
Fan, W., Cheng, K., Qin, X., Narsinh, K. H., Wang, S., Hu, S., Wang, Y., Chen, Y., Wu, J. C., Xiong, L., et al. (2012) · Stem Cells · doi:10.1002/stem.1265 · Cited by 56
Chintala, H., Krupska, I., Yan, L., Lau, L., Grant, M., & Chaqour, B. (2015) · Development · doi:10.1242/dev.121913 · Cited by 52
“Phosphorylation at Y1175 supports EC survival and proliferation by inducing Akt and mitogen-activated protein kinase (MAPK) p44/42 phosphorylation, whereas phosphorylation at the Y1214 site promotes p38 activation and cell migration (Olsson et al., 2006).”
BackgroundConrady, C. D., Zheng, M., Stone, D. U., & Carr, D. J. J. (2012) · The Journal of Immunology · doi:10.4049/jimmunol.1200063 · Cited by 53
“However, the few unwarranted effects of these cells within the cornea likely results from the secretion of VEGF isoforms to initiate endothelial migration and proliferation (30).”
BackgroundGrowth Factors as Active Participants in Carcinogenesis: A Perspective
Halper, J. T. (2009) · Veterinary Pathology · doi:10.1177/0300985809352981 · Cited by 62
Qi, J.-W., Qin, T., Xu, L., Zhang, K., Yang, G., Li, J., Xiao, H., Zhang, Z., & Li, L. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1304529110 · Cited by 53
“It is known that mFlt1 mediates VEGF-induced endothelial nitric oxide synthase (eNOS) and MAPK p38 phosphorylation in EC (19, 48), and that mFlt1 mediates PlGF-induced p38 activation (49).”
BackgroundTowards a new classification of gastroenteropancreatic neuroendocrine neoplasms
Kidd, M. S., Modlin, I. M., & Öberg, K. (2016) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2016.85 · Cited by 54
VEGF - A Stimulus for Neuronal Development and Regeneration in the CNS and PNS
Theis, V., & Theiß, C. (2018) · Current Protein and Peptide Science · doi:10.2174/1389203719666180104113937 · Cited by 57
Masłowska, K., Halik, P. K., Tymecka, D., Misicka, A., & Gniazdowska, E. (2021) · Cancers · doi:10.3390/cancers13051072 · Cited by 57
“All VEGF isoforms that bind selectively to VEGFR-2 are capable to elicit receptor autophosphorylation, thus triggering the activation of numerous intracellular signalling pathways (Figure 2) [58,100,103,106,107].”
BackgroundYue, X., Hariri, D. J., Caballero, B., Zhang, S., Bartlett, M. J., Kaut, O., Mount, D. W., Wüllner, U., Sherman, S. J., & Falk, T. (2013) · Neuroscience · doi:10.1016/j.neuroscience.2013.11.038 · Cited by 55
“VEGF-A is the most studied VEGF family member but due to its angiogenic capabilities but is less suitable for use as a neurotrophic agent (Olsson et al., 2006).”
InfluentialOguro, Y., Cary, D. R., Miyamoto, N., Tawada, M., Iwata, H., Miki, H., Hori, A., & Imamura, S. (2013) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2013.04.042 · Cited by 53
The ADMA/DDAH Pathway Regulates VEGF-Mediated Angiogenesis
Fiedler, L. R., Bachetti, T., LEIPER, J. M., Zachary, I. C., Chen, L., Renné, T., & Wójciak‐Stothard, B. (2009) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.109.194035 · Cited by 55
Tumor Vessel Normalization: A Window to Enhancing Cancer Immunotherapy
Li, S., Zhang, Q., & Hong, Y. (2020) · Technology in Cancer Research & Treatment · doi:10.1177/1533033820980116 · Cited by 54
“The binding of VEGFA and VEGFR2 initiates the dominant pathway of angiogenesis.(47) Additionally, excessive amounts of VEGF also induce the development of immunosuppression in the TME via at least 3 mechanisms.”
BackgroundThe Role of Hypoxia and Cancer Stem Cells in Development of Glioblastoma
Shi, T., Zhu, J., Zhang, X., & Mao, X. (2023) · Cancers · doi:10.3390/cancers15092613 · Cited by 56
“In hypoxia, both VEGF and VEGFR2 are up-regulated by HIF1α and overexpressed in GBM, accelerating tumor progression and invasion [43].”
BackgroundFluid flow to mimic organ function in 3D in vitro models
Juste-Lanas, Y., Hervás-Raluy, S., García‐Aznar, J. M., & González‐Loyola, A. (2023) · APL Bioengineering · doi:10.1063/5.0146000 · Cited by 55
Regulation of signaling interactions and receptor endocytosis in growing blood vessels
Pitulescu, M. E., & Adams, R. H. (2014) · Cell Adhesion & Migration · doi:10.4161/19336918.2014.970010 · Cited by 56
“34 VEGF-A binds VEGFR1 and VEGFR2.”
BackgroundInfluentialZhang, Q., Yu, C., Peng, S., Xu, H., Wright, E., Zhang, X., Huo, X., Cheng, E., Pham, T. H., Asanuma, K., et al. (2013) · Gastroenterology · doi:10.1053/j.gastro.2013.10.011 · Cited by 52
“VEGFR2 is known to activate ERK1/2 directly through Ras, or indirectly via the PLC/PKC pathway.(18) Our observation that siRNA against PLC-γ1 markedly reduced”
Ikeda, T., Sun, L., Tsuruoka, N., Ishigaki, Y., Yoshitomi, Y., Yoshitake, Y., & Yonekura, H. (2011) · Biochemical Journal · doi:10.1042/bj20101490 · Cited by 52
Yu, Y., Chen, J., Chen, R., Cao, L., Tang, W., Lin, D., Wang, J., & Liu, C. (2015) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.5b02324 · Cited by 58
Apelin: A putative novel predictive biomarker for bevacizumab response in colorectal cancer
Zuurbier, L. C., Rahman, A., Cordes, M., Scheick, J. R., Wong, T. J., Rustenburg, F., Joseph, J., Dynoodt, P., Casey, R., Drillenburg, P., et al. (2017) · Oncotarget · doi:10.18632/oncotarget.17306 · Cited by 54
“VEGF signalling is one of the most ubiquitous growth factor signalling pathways to regulate angiogenesis under normal physiological, but also pathological conditions [3].”
BackgroundKofler, N. M., Corti, F., Rivera-Molina, F. E., Deng, Y., Toomre, D. K., & Simons, M. (2018) · Journal of Biological Chemistry · doi:10.1074/jbc.m117.812172 · Cited by 56
Vascular Endothelial Growth Factor Receptor 3 Regulates Endothelial Function Through β-Arrestin 1
Ma, Z., Yu, Y.-R. A., Badea, C. T., Kovacs, J. J., Xiong, X., COMHAIR, S. A. A., Piantadosi, C. A., & Rajagopal, S. (2019) · Circulation · doi:10.1161/circulationaha.118.034961 · Cited by 52
Hypoxia‐induced endothelial cell responses – possible roles during periodontal disease
Mendes, R. T., Nguyen, D., Stephens, D. N., Pamuk, F., Fernandes, D., Hastürk, H., Dyke, T. E. V., & Kantarcı, A. (2018) · Clinical and Experimental Dental Research · doi:10.1002/cre2.135 · Cited by 52
“Vascular changes are an important aspect of the onset of chronic periodontitis (Olsson, Dimberg, Kreuger, & Claesson‐Welsh, 2006; Zoellnor & Hunter, 1991) as well as other inflammatory lesions, cancer metastases, wound healing, atherosclerosis, tumor growth and angiogenesis (Paris et al., 2005).”
BackgroundMethodZhou, Z., Mao, W., Li, Y., Qi, C., & He, Y. (2019) · The Anatomical Record · doi:10.1002/ar.24222 · Cited by 52
“It inhibits cancer cell proliferation (Maggioni et al., 2014; Zang et al., 2014; Huang et al., 2015a; Jose et al., 2016), promotes apoptosis (Zhang et al., 2014; Huang et al., 2015a, 2015b; Seydi et al., 2016; Xu et al., 2016), and enhances cancer cell radiosensitivity (Zhang et al., 2014).”
BackgroundEngelbrecht, E., Levesque, M. V., He, L., Vanlandewijck, M., Nitzsche, A., Niazi, H., Kuo, A., Singh, S. A., Aikawa, M., Holton, K. M., et al. (2020) · eLife · doi:10.7554/elife.52690 · Cited by 53
“The 16 ECKO up-regulated transcripts included positive regulators of angiogenesis (Pgf, Apold1, Itga6, Kdr) (Mirza et al., 2013; Olsson et al., 2006; Primo et al., 2010), regulators of GPCR signaling (Rgs2, Rasgrp3), and Cx3cl1 (Fractalkine), which encodes a potent monocyte chemoattractant (White and Greaves, 2012).”
BackgroundCheng, K., Liu, C., & Rao, G. (2020) · Current Medicinal Chemistry · doi:10.2174/0929867327666200514082425 · Cited by 55
Solute Transport in Growth Plate Cartilage: In Vitro and In Vivo
Williams, R. M., Zipfel, W. R., Tinsley, M. L., & Farnum, C. E. (2007) · Biophysical Journal · doi:10.1529/biophysj.106.097675 · Cited by 62
“This would require no physical change in position of the molecule Biophysical Journal 93(3) 1039–1050 itself within the ECM; time would, in effect, negate any requirement of movement, since the cell that originally synthesized the molecule could mature and subsequently react to it (61).”
BackgroundInfluentialHao, Q., Wang, L., Zhao, Z. J., & Tang, H. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m807546200 · Cited by 52
Schomber, T., Kopfstein, L., Djonov, V., Albrecht, I., Baeriswyl, V., Strittmatter, K., & Christofori, G. (2007) · Cancer Research · doi:10.1158/0008-5472.can-07-1034 · Cited by 52
“The VEGF family members have in common a cysteine knot VEGF homology domain and exert their varying functions on blood and/ or lymph vessel angiogenesis by differentially binding to their cognate receptors VEGFR-1, VEGFR-2, and VEGFR-3 (9, 10 ).”
BackgroundChai, W., Fu, Z., Aylor, K. W., Barrett, E. J., & Liu, Z. (2016) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00205.2016 · Cited by 51
The HOTAIR lncRNA: A remarkable oncogenic promoter in human cancer metastasis (Review)
Chen, L., Qian, X., Wang, Z., & Zhou, X. (2021) · Oncology Letters · doi:10.3892/ol.2021.12563 · Cited by 55
“Among angiogen‐ esis factors, VEGF, a highly specific vascular endothelial growth factor, plays a vital role in the extracellular matrix and vascular endothelial cells (67).”
BackgroundSahebkar, A., Ponziani, M. C., Goitre, I., & Bo, S. (2015) · Metabolism · doi:10.1016/j.metabol.2015.08.002 · Cited by 51
Involvement of Girdin in the Determination of Cell Polarity during Cell Migration
Ohara, K., Enomoto, A., Kato, T., Hashimoto, T., Isotani-Sakakibara, M., Asai, N., Takagishi, M., Weng, L., Nakayama, M., Watanabe, T., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0036681 · Cited by 55
Essential Role of Apelin Signaling During Lymphatic Development in Zebrafish
Kim, J., Kang, Y., Kim, J. M., Papangeli, I., Kang, H., Wu, J., Park, H., Nadelmann, E. R., Rockson, S. G., Chun, H. J., et al. (2013) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.113.302785 · Cited by 51
Life is a pattern: vascular assembly within the embryo
Heinke, J., Patterson, C., & Moser, M. (2011) · Frontiers in Bioscience-Elite · doi:10.2741/541 · Cited by 64
“On the other hand, VEGFA leads to weak phosphorylation of VEGFR1 (65), and additionally VEGFR1 is reported to crosstalk with VEGFR2, which may result in either inhibitory or stimulatory activity dependent on the biological context (reviewed in reference (66)).”
BackgroundCôté, M. C., Lavoie, J. R., Houle, F., Poirier, A., Rousseau, S., & Huot, J. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.098665 · Cited by 51
Sallinen, H., Anttila, M., Närväinen, J., Koponen, J., Hämäläinen, K. M., Kholová, I., Heikura, T., Toivanen, P. I., Kosma, V., Heinonen, S. T., et al. (2008) · Molecular Therapy · doi:10.1038/mt.2008.258 · Cited by 51
Sarnelli, G., D’Alessandro, A., Iuvone, T., Capoccia, E., Gigli, S., Pesce, M., Seguella, L., Nobile, N., Aprea, G., Maione, F., et al. (2016) · PLoS ONE · doi:10.1371/journal.pone.0156198 · Cited by 53
Tan, J. T. M., Prosser, H. C. G., Dunn, L., Vanags, L. Z., Ridiandries, A., Tsatralis, T., Lecce, L., Clayton, Z. E., Yuen, S. C. G., Robertson, S. E. J., et al. (2016) · Diabetes · doi:10.2337/db15-1668 · Cited by 54
“pVEGFR2 induces the activation of an array of angiogenic signaling pathways (35).”
Background3-Alkenyl-2-oxindoles: Synthesis, antiproliferative and antiviral properties against SARS-CoV-2
Girgis, A. S., Panda, S. S., Srour, A. M., Abdelnaser, A., Nasr, S., Moatasim, Y., Kutkat, O., Taweel, A. E., Kandeil, A., Mostafa, A., et al. (2021) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2021.105131 · Cited by 51
“It has been reported that vascular endothelial growth factor receptors are three main categories (VEGFR-1, VEGFR-2, and VEGFR-3) responsible for tumor angiogenesis [75,76].”
Gastroschisis: A gene–environment model involving the VEGF–NOS3 pathway
Lammer, E. J., Iovannisci, D. M., Tom, L., Schultz, K., & Shaw, G. M. (2008) · American Journal of Medical Genetics Part C Seminars in Medical Genetics · doi:10.1002/ajmg.c.30182 · Cited by 52
“VEGF (also known as VEGFA) is a homodimeric secreted glycoprotein that selectively acts on endothelial cells via two tyrosine kinase surface receptors, VEGFR1 and VEGFR2 [Byrne et al., 2005; Coultas et al., 2005; Olsson et al., 2006; Shibuya, 2006].”
BackgroundTaghour, M. S., Elkady, H., Eldehna, W. M., El‐Deeb, N. M., Kenawy, A. M. A., Elkaeed, E. B., Alsfouk, B. A. A., Alesawy, M. S., Husein, D. Z., Metwaly, A. M., et al. (2022) · PLoS ONE · doi:10.1371/journal.pone.0272362 · Cited by 50
Amer, M. S., McKeown, L., Tumova, S., Liu, R., Seymour, V. A. L., Wilson, L. A., Naylor, J., Greenhalgh, K., Hou, B., Majeed, Y., et al. (2012) · British Journal of Pharmacology · doi:10.1111/bph.12041 · Cited by 50
“A key extracellular signalling molecule in physiological and tumour angiogenesis is VEGF, which acts via VEGF receptors of the receptor tyrosine kinase superfamily (Olsson et al ., 2006).”
Dynamics of VEGF matrix-retention in vascular network patterning
Köhn‐Luque, A., de Back, W., Yamaguchi, Y., Yoshimura, K., Herrero, M. A., & Miura, T. (2013) · Physical Biology · doi:10.1088/1478-3975/10/6/066007 · Cited by 56
“VEGF binding to cell surface tyrosine kinase VEGF receptor-2 (VEGFR2) activates, among others, multiple downstream pathways related to actin reorganization, filopodia extension and invasive, protrusive behaviour [5, 6].”
BackgroundThe glioblastoma vasculature as a target for cancer therapy
Dimberg, A. (2014) · Biochemical Society Transactions · doi:10.1042/bst20140278 · Cited by 52
Self-citationAngiogenic therapy for cardiac repair based on protein delivery systems
Formiga, F. R., Tamayo, E., Simón‐Yarza, T., Pelacho, B., Prósper, F., & Blanco‐Prieto, M. J. (2011) · Heart Failure Reviews · doi:10.1007/s10741-011-9285-8 · Cited by 57
Norcantharidin inhibits tumor angiogenesis via blocking VEGFR 2/ MEK / ERK signaling pathways
Zhang, L., Ji, Q., Liu, X., Chen, X., Chen, Z., Qiu, Y., Sun, J., Cai, J., Zhu, H., & Li, Q. (2013) · Cancer Science · doi:10.1111/cas.12120 · Cited by 50
Meissirel, C., de Almodóvar, C. R., Knevels, E., Coulon, C., Chounlamountri, N., Segura, I., Rossi, P. D., Vinckier, S., Anthonis, K., Deleglise, B., et al. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1100341108 · Cited by 57
“Immunoblotting for αSrc-pTyr416 showed that VEGF activated SFKs (Fig.”
BackgroundResultInfluentialBiomarkers of endothelial dysfunction in preeclampsia and neonatal morbidity: a case–control study
Masoura, S., Kalogiannidis, I. A., Makedou, K., Theodoridis, T., Koiou, K., Gerou, S., Athanasiadis, A. P., & Αγοραστός, Θ. (2014) · European Journal of Obstetrics & Gynecology and Reproductive Biology · doi:10.1016/j.ejogrb.2014.01.012 · Cited by 50
Jörgens, K., Stoll, S. J., Pohl, J., Fleming, T. H., Sticht, C., Nawroth, P. P., Hammes, H., & Krøll, J. (2014) · Diabetes · doi:10.2337/db14-0352 · Cited by 58
“VEGF binds to VEGF receptor 2 and activates its intrinsic tyrosine kinase domain, leading to a rapid and strong autophosphorylation of VEGF receptor 2, activation of its downstream signaling pathways, and eventually blood vessel formation (36).”
BackgroundMethodInfluentialTemporal-specific roles of Rac1 during vascular development and retinal angiogenesis
Nohata, N., Uchida, Y., Stratman, A. N., Adams, R. H., Zheng, Y., Weinstein, B. M., Mukouyama, Y., & Gutkind, J. S. (2016) · Developmental Biology · doi:10.1016/j.ydbio.2016.02.005 · Cited by 51
“Rac1 activity is increased by VEGF (Tan et al., 2008), S1P (Tauseef et al., 2008), platelet activating factor (Knezevic et al., 2009), interleukin 8 (Gavard et al., 2009), and Prostaglandin E2 or I2 (Birukova et al., 2007).”
BackgroundInfluentialBuilding blood vessels in development and disease
Kushner, E. J., & Bautch, V. L. (2013) · Current Opinion in Hematology · doi:10.1097/moh.0b013e328360614b · Cited by 53
“Developmental angiogenesis results from a delicate balance of both pro-angiogenic and anti-angiogenic cues in both space and time [4,5].”
BackgroundModulation of VEGF receptor 2 signaling by protein phosphatases
Corti, F., & Simons, M. (2016) · Pharmacological Research · doi:10.1016/j.phrs.2016.11.022 · Cited by 51
“Furthermore, knock-in mice which express only selected VEGFA splicing isoforms show marked phenotype differences; this suggests some degree of function segregation between the isoforms [16, 19]”
BackgroundSUMOylation Negatively Regulates Angiogenesis by Targeting Endothelial NOTCH Signaling
Zhu, X., Ding, S., Qiu, C., Shi, Y., Song, L., Wang, Y., Wang, Y., Li, J., Wang, Y., Sun, Y., et al. (2017) · Circulation Research · doi:10.1161/circresaha.117.310696 · Cited by 50
Multisite Phosphorylation of S6K1 Directs a Kinase Phospho-code that Determines Substrate Selection
Arif, A., Jia, J., Willard, B. B., Li, X., & Fox, P. L. (2019) · Molecular Cell · doi:10.1016/j.molcel.2018.11.017 · Cited by 54
“Receptor tyrosine kinases exhibit phospho-codes that determine binding to adaptors without directly influencing target selection or phosphorylation (Olsson et al., 2006).”
Molecular Docking Studies of a Cyclic Octapeptide-Cyclosaplin from Sandalwood
Mishra, A., & Dey, S. (2019) · Biomolecules · doi:10.3390/biom9110740 · Cited by 54
“The unique polar region involves several residues such as Asn921, Cys1043, Arg1030 and Asn1031 [32].”
BackgroundLi, X., Hong, M., Chen, J., Lu, Y., Ye, M., Ma, Y., Zhu, D., & Gao, P. (2019) · Cardiovascular Research · doi:10.1093/cvr/cvz159 · Cited by 51
Pathological Circulating Factors in Moyamoya Disease
Fang, Y.-C., Wei, L.-F., Hu, C., & Tu, Y. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22041696 · Cited by 50
“are both related to pathological angiogenesis [14,15,38].”
BackgroundInfluentialBlocking Jak/STAT signalling using tofacitinib inhibits angiogenesis in experimental arthritis
Benedetto, P. D., Ruscitti, P., Berardicurti, O., Panzera, N., Grazia, N., Nolfi, M. D. V., Francesco, B. D., Navarini, L., Maurizi, A., Rucci, N., et al. (2021) · Arthritis Research & Therapy · doi:10.1186/s13075-021-02587-8 · Cited by 53
“The JAK family includes 4 members, JAK-1, JAK-2, JAK-3 and tyrosine kinase 2 (TYK2), which are variously combined with cytokines receptors to transmit cellular signalling [10].”
BackgroundInfluentialBrief Report: Chylothorax and Chylous Ascites During RET Tyrosine Kinase Inhibitor Therapy
Kalchiem‐Dekel, O., Falcon, C. J., Bestvina, C. M., Liu, D., Kaplanis, L. A., Wilhelm, C., Eichholz, J., Harada, G., Wirth, L. J., Digumarthy, S. R., et al. (2022) · Journal of Thoracic Oncology · doi:10.1016/j.jtho.2022.06.008 · Cited by 50
Metadata
- Authors
- Olsson, A.-K., Dimberg, A., Kreuger, J., & Claesson-Welsh, L.
- Affiliations
- Uppsala University (SE)
- Venue
- Nature Reviews Molecular Cell Biology
- Published
- 2006-05
- Volume
- 7
- Issue
- 5
- Pages
- 359-371
- ISSN
- 1471-0072 (ISSN-L)
- 1471-0080
- OpenAlex
- W2091774189
- Cited by
- 3,122
- References
- 141
- Citations by year
- 2026: 88 · 2025: 107 · 2024: 116 · 2023: 127 · 2022: 127 · 2021: 158 · 2020: 160 · 2019: 156 · 2018: 156 · 2017: 176 · 2016: 202 · 2015: 184 · 2014: 212 · 2013: 231 · 2012: 190
- FWCI
- 10.42
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Reviews Molecular Cell Biology (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Vetenskapsrådet
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Angiogenesis and VEGF in Cancer
- Health Sciences › Medicine › Oncology › Lymphatic System and Diseases
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Axon Guidance and Neuronal Signaling
- Keywords
- VEGF receptors, VEGF signaling, VEGFR1, VEGFR2, VEGFR-3, angiogenesis, pathological angiogenesis, vascular development, endothelial cells, signal transduction, anti-angiogenic cancer therapy
- MeSH terms
- Animals, Humans, Stem Cells, Signal Transduction, Neovascularization, Physiologic, Receptors, Vascular Endothelial Growth Factor, Vascular Endothelial Growth Factors, Embryonic Development
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.